Mill Creek Life Sciences

Mill Creek Life Sciences LLC provides tools and technologies to support the development and application of cell and biotherapies. It is involved in the development, licensing, and commercialization of intellectual property, patents, and proprietary technologies related to the production of cell culture supplements. The company develops products to supplement cell culture for clinical and research markets focused on stem cells and primary cells. Its product portfolio includes PLTMax, which is derived from normal human donor platelets collected by U.S. centers. Mill Creek Life Sciences LLC was founded in 2010 and is headquartered in Rochester, Minnesota.